Palisade Bio, Inc. Common Stock

PALINASDAQUSD
2.11 USD
0.03 (1.17%)🟢LIVE (AS OF 03:29 PM EDT)
🟢Market: OPEN

Palisade Bio, Inc. Common Stock (PALI) trades at $2.11 per share. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, PALI is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Aug 26, 2026.

Open?$2.12
High?$2.16
Low?$2.11
Prev. Close?$2.13
Volume?622.5K
Avg. Volume?1.9M
VWAP?$2.12
Rel. Volume?0.33x
Bid / Ask
Bid?$2.10 × 3.9K
Ask?$2.11 × 10.0K
Spread?$0.01
Midpoint?$2.11
Valuation & Ratios
Market Cap?371.2M
Shares Out?174.3M
Float?165.0M
Float %?99.4%
P/E Ratio?N/A
P/B Ratio?3.05
EPS?-$0.18
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Employees
14
Market Cap
371.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-04-28
Address
7750 EL CAMINO REAL, SUITE 5200
CARLSBAD, CA 92009
Phone: (858) 704-4900
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
39
Piotroski F-Score?0/9Weak
Altman Z-Score?38.34Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?20.24%Squeeze Risk
Short Interest?33.4M
Days to Cover?22.0
Free Float165.0M
Avg Daily Volume1.5M
Settlement Date2026-08-14
Financial Health
Current Ratio?24.26Strong
Quick Ratio?24.26Strong
Cash Ratio?23.86Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A
P/B?
Peers
100
S&P
55
3.05FAIR
P/S?
Peers
100
S&P
3
742.39HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-7.0CHEAP
EV/Sales?
Peers
100
S&P
3
492.05HIGH
Returns & Efficiency
ROE?
S&P
7
-26.2%WEAK
ROA?
S&P
3
-25.1%WEAK
Cash Flow & Enterprise
FCF?$-18190000
Enterprise Value?$246.0M
Fundamentals ratios updated end of day